id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-P-6094-0013,FDA,FDA-2025-P-6094,Interim Response,Other,Letter(s),2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T18:33:39Z,,0,0,09000064b92cf88c
FDA-2025-P-6094-0012,FDA,FDA-2025-P-6094,SSRI listening session minutes_3-24-26,Other,Memorandum,2026-04-24T04:00:00Z,2026,4,2026-04-24T04:00:00Z,,2026-04-24T18:28:27Z,,0,0,09000064b92a5f88
FDA-2025-P-6094-0005,FDA,FDA-2025-P-6094,Sources – Part 3,Supporting & Related Material,Background Material,2025-11-17T05:00:00Z,2025,11,,,2025-11-18T02:12:15Z,,0,0,09000064b908414f
FDA-2025-P-6094-0008,FDA,FDA-2025-P-6094,Sources – Part 6,Supporting & Related Material,Background Material,2025-11-17T05:00:00Z,2025,11,,,2025-11-18T02:12:33Z,,0,0,09000064b9086066
FDA-2025-P-6094-0004,FDA,FDA-2025-P-6094,Sources – Part 2,Supporting & Related Material,Background Material,2025-11-17T05:00:00Z,2025,11,,,2025-11-18T02:12:10Z,,0,0,09000064b908414e
FDA-2025-P-6094-0006,FDA,FDA-2025-P-6094,Sources – Part 4,Supporting & Related Material,Background Material,2025-11-17T05:00:00Z,2025,11,,,2025-11-18T02:12:20Z,,0,0,09000064b9086064
FDA-2025-P-6094-0003,FDA,FDA-2025-P-6094,Sources – Part 1,Supporting & Related Material,Background Material,2025-11-17T05:00:00Z,2025,11,,,2025-11-18T02:12:05Z,,0,0,09000064b908414d
FDA-2025-P-6094-0007,FDA,FDA-2025-P-6094,Sources – Part 5,Supporting & Related Material,Background Material,2025-11-17T05:00:00Z,2025,11,,,2025-11-18T02:12:27Z,,0,0,09000064b9086065
FDA-2025-P-6094-0010,FDA,FDA-2025-P-6094,Sources – Part 8,Supporting & Related Material,Background Material,2025-11-17T05:00:00Z,2025,11,,,2025-11-18T02:12:47Z,,0,0,09000064b9086068
FDA-2025-P-6094-0001,FDA,FDA-2025-P-6094,Citizen Petition from Public Citizen's Health Research Group,Other,Citizen Petition,2025-11-17T05:00:00Z,2025,11,2025-11-17T05:00:00Z,,2025-11-18T01:07:07Z,,1,0,09000064b9086491
FDA-2025-P-6094-0009,FDA,FDA-2025-P-6094,Sources – Part 7,Supporting & Related Material,Background Material,2025-11-17T05:00:00Z,2025,11,,,2025-11-18T02:12:40Z,,0,0,09000064b9086067
FDA-2025-P-6094-0002,FDA,FDA-2025-P-6094,Acknowledgement Letter from FDA DMB to Public Citizen's Health Research Group,Other,Acknowledgement Letter/Receipt,2025-11-17T05:00:00Z,2025,11,2025-11-17T05:00:00Z,,2025-11-18T01:07:13Z,,0,0,09000064b9086493
FDA-2025-P-6094-0011,FDA,FDA-2025-P-6094,Sources – Part 9,Supporting & Related Material,Background Material,2025-11-17T05:00:00Z,2025,11,,,2025-11-18T02:12:53Z,,0,0,09000064b9086069